The redesigned 2026 Audi Q3 gains more power, a bit more cargo room and several new technology features, all of which give it ...
The compact SUV is powered by a 1.5L Revotron naturally aspirated petrol engine producing 106 PS and 145 Nm of torque, a 1.5L ...
JSW MG Motor’s Majestor. Compared to MG’s own Gloster, Majestor trumps in all aspects.It is the lo ...
Quest Resource Holding Corporation (NASDAQ:QRHC) Q4 2025 Earnings Call Transcript March 12, 2026 Quest Resource Holding ...
RealTruck.com reports on the latest truck accessories, featuring new products to enhance vehicle performance and style.
Good afternoon, ladies and gentlemen, and welcome to Quest Resource Holding Corporation Fourth Quarter 2025 Earnings Call Conference Call. [Operator Instructions] Please be advised that this call is ...
Thank you for standing by, and welcome to ATRenew Inc.'s Fourth Quarter and Full Year 2025 Earnings Conference Call. [Operator Instructions] Please note, today's event is being recorded. I will now ...
Gross profit for fiscal 2025 reached $46.3 million, while operating expenses were tightly managed despite temporary spikes from bad debt and year-end adjustments. LFP: Lithium iron phosphate, a ...
Vera Bradley, Inc. (NASDAQ:VRA) Q4 2026 Earnings Call Transcript March 12, 2026 Vera Bradley, Inc. beats earnings expectations. Reported EPS is $0.09239, expectations were $0.01. Operator: Greetings, ...
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
A hands-on comparison between the two shows how the latest image models differ on price, speed, and creative control.
Clinically available KRAS inhibitors mainly target G12C, which is rare in PDAC and often acquires resistance. Oncogenic KRAS inactivates RB1 via CDK4/6, while RB1 mutation is rare. Thus, CDK4/6 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results